Dapsone: Difference between revisions
ClaireLewis (talk | contribs) |
(Text replacement - "qd" to "QD") |
||
Line 6: | Line 6: | ||
==Adult Dosing== | ==Adult Dosing== | ||
*Hansen disease (leprosy) | *Hansen disease (leprosy) | ||
**paucibacillary: 100mg PO | **paucibacillary: 100mg PO QD x6mo | ||
***Use with rifampin | ***Use with rifampin | ||
**multibacillary: 100mg PO | **multibacillary: 100mg PO QD x12mo | ||
***Use with rifampin, clofazimine | ***Use with rifampin, clofazimine | ||
*Dermatitis herpetiformis: 50mg PO | *Dermatitis herpetiformis: 50mg PO QD | ||
*PCP prophylaxis: 100mg/day PO divided | *PCP prophylaxis: 100mg/day PO divided QD-bid | ||
**Off label use | **Off label use | ||
*PCP treatment: 100mg PO | *PCP treatment: 100mg PO QD x21 days | ||
**Not 1st-line agent; use with trimethoprim | **Not 1st-line agent; use with trimethoprim | ||
**Off label use | **Off label use | ||
Line 24: | Line 24: | ||
**Off label use | **Off label use | ||
*[[Toxoplasmosis]] prophylaxis: 50mg PO | *[[Toxoplasmosis]] prophylaxis: 50mg PO QD | ||
**Off label use | **Off label use | ||
Revision as of 08:59, 7 July 2017
Administration
- Type: Antibiotic
- Dosage Forms: 25,100
- Routes of Administration: Oral
Adult Dosing
- Hansen disease (leprosy)
- paucibacillary: 100mg PO QD x6mo
- Use with rifampin
- multibacillary: 100mg PO QD x12mo
- Use with rifampin, clofazimine
- paucibacillary: 100mg PO QD x6mo
- Dermatitis herpetiformis: 50mg PO QD
- PCP prophylaxis: 100mg/day PO divided QD-bid
- Off label use
- PCP treatment: 100mg PO QD x21 days
- Not 1st-line agent; use with trimethoprim
- Off label use
- Malaria suppression: 100mg PO qwk
- Use with pyrimethamine
- Off label use
- Toxoplasmosis prophylaxis: 50mg PO QD
- Off label use
Pediatric Dosing
Special Populations
- Pregnancy Rating: C
- Lactation risk: Probably unsafe
Renal Dosing
- No adjustment
Hepatic Dosing
- Caution advised with hepatic impairment
- CBC qwk x4, qmo x6, then q6mo thereafter
- LFTs at baseline, then periodically
Contraindications
- Allergy to class/drug
- caution if renal or hepatic impairment
- caution if impaired cardiovascular function
Adverse Reactions
Serious
- anemia, hemolytic
- aplastic anemia
- agranulocytosis
- exfoliative dermatitis
- erythema multiforme
- toxic epidermal necrolysis
Common
- fever
- myalgia
- headache
- rigors
- fatigue
- malaise
- dizziness
Pharmacology
- Half-life: 28 hrs
- Metabolism: Liver, CYP450
- Excretion: Urine